Catalog No.
RVV11501
Expression system
Mammalian Cells
Species reactivity
Hepatitis B virus genotype D subtype adw (isolate United Kingdom/adyw/1979)(HBV-D) (P03147), Hepatitis B virus genotype D subtype ayw (isolate France/Tiollais/1979)(HBV-D)(P0C573)
Host species
Human
Isotype
IgG1
Clonality
Monoclonal
Target
Capsid protein, Core antigen, Core protein, HBcAg, p21.5, C
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P03147
Applications
ELISA, SPR
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
E13#
Interpretation of HBV Serologies. PMID: 34593148
Evaluation of pregenomic HBV RNA in HBeAg-negative patients. PMID: 35699558
How to manage HBeAg-negative chronic HBV infection with normal alanine aminotransferase levels in clinical practice? PMID: 23167981
Hepatitis B Flare in Hepatitis B e Antigen-Negative Patients: A Complicated Cascade of Innate and Adaptive Immune Responses. PMID: 35163476
Letter to the editor: HBeAg expression suppressing/abolishing mutation elevated HBV DNA level in HBeAg-negative patients with chronic HBV infection. PMID: 35383987
Virological activity in treatment-naïve HBeAg-negative HBV-infected adult patients: A community-based study in Jiangsu, China. PMID: 32702877
Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA: A community-based study. PMID: 28816955
HBeAg-positive patients with HBsAg < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation. PMID: 34292372
Is the function of the HBeAg really unknown? PMID: 31063442
Serum HBV RNA as a predictor of virological response in treatment-naive chronic HBeAg-positive HBV-infected patients with normal alanine aminotransferase. PMID: 36535012
HBeAg Is Indispensable for Inducing Liver Sinusoidal Endothelial Cell Activation by Hepatitis B Virus. PMID: 35174107
Relationship between HBeAg and HBV DNA in patients with acute and persistent hepatitis B infection. PMID: 3773827
The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma. PMID: 37112837
HBeAg/anti-HBe, alanine aminotransferase and HBV DNA levels in HBsAg positive chronic carriers. PMID: 19119537
The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics. PMID: 27139263
Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers. PMID: 21352567
A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. PMID: 22749833
Hepatitis B virus e antigen and viral persistence. PMID: 34717215
[Induction of seroconversion in HBeAg expressing transgenic mice--comparison of murine model to HBV carriers]. PMID: 12442371
Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. PMID: 32805201
Comparison of detection and quantification of HBV DNA in chronic HBeAg negative and positive patients by Abbott RealTime HBV and Roche Cobas TaqMan HBV assays. PMID: 23835030
Relationship between Maternal PBMC HBV cccDNA and HBV Serological Markers and its Effect on HBV Intrauterine Transmission. PMID: 31217048
A model to predict liver damage in patients with HBeAg-positive chronic HBV infection. PMID: 34091417
HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene. PMID: 29085029
HBV genotype B/C and response to lamivudine therapy: a systematic review. PMID: 24364035
Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas. PMID: 36851587
HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection. PMID: 24976702
A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice. PMID: 28426720
Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators. PMID: 27185623
Effect of lamivudine in HBeAg-positive chronic hepatitis B: discordant effect on HBeAg and HBV DNA according to pretreatment ALT level. PMID: 15948237
Deacetylation of Notch1 by SIRT1 contributes to HBsAg- and HBeAg-mediated M2 macrophage polarization. PMID: 35234049
[Generation of a novel HBeAg transgenic mice using CRISPR/Cas9 technique]. PMID: 31640958
HBcrAg and pg RNA and the therapeutic effect in HBeAg-positive patients receiving anti-viral therapy, baseline serum HBV-RNA is a powerful predictor of response. PMID: 32277539
Identification of dihydroquinolizinone derivatives with cyclic ether moieties as new anti-HBV agents. PMID: 35700597
[The relationship of HBeAg status with HBV DNA loads, MELD scores in patients with acute-on-chronic hepatitis B liver failure during terminal phases]. PMID: 22919755
Can we stop nucleoside analogues before HBsAg loss? PMID: 30803099
Inhibition of HBsAg and HBeAg expression by shRNA expressing vectors targeting HBV s and e gene. PMID: 21351686
Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests. PMID: 12118438
[Clinical significance and natural history of "HBeAg negativity" in patients with chronic HBV infection]. PMID: 16804337
Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau. PMID: 21494570
HBeAg(+) and sex ratio of offspring: evidence form Taiwan's three million newborns. PMID: 22431495